Your browser doesn't support javascript.
loading
α-lipoic acid reduces postreperfusion syndrome in human liver transplantation - a pilot study.
Casciato, Paola; Ambrosi, Nella; Caro, Fiorella; Vazquez, Mónica; Müllen, Eduardo; Gadano, Adrian; de Santibañes, Eduardo; de Santibañes, Martín; Zandomeni, Marcos; Chahdi, Magali; Lazarte, Julio C; Biagiola, David A; Iaquinandi, Juan Cruz; Santofimia-Castaño, Patricia; Iovanna, Juan; Incardona, Claudio; Chuluyan, Eduardo.
Afiliação
  • Casciato P; Unidad de Trasplante Hepático, Hospital Italiano, Buenos Aires, Argentina.
  • Ambrosi N; Facultad de Medicina, CEFYBO-CONICET, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Caro F; Facultad de Medicina, CEFYBO-CONICET, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Vazquez M; Unidad de Trasplante Hepático, Hospital Italiano, Buenos Aires, Argentina.
  • Müllen E; Unidad de Trasplante Hepático, Hospital Italiano, Buenos Aires, Argentina.
  • Gadano A; Unidad de Trasplante Hepático, Hospital Italiano, Buenos Aires, Argentina.
  • de Santibañes E; Unidad de Trasplante Hepático, Hospital Italiano, Buenos Aires, Argentina.
  • de Santibañes M; Unidad de Trasplante Hepático, Hospital Italiano, Buenos Aires, Argentina.
  • Zandomeni M; Unidad de Trasplante Hepático, Hospital Italiano, Buenos Aires, Argentina.
  • Chahdi M; Unidad de Trasplante Hepático, Hospital Italiano, Buenos Aires, Argentina.
  • Lazarte JC; Unidad de Trasplante Hepático, Hospital Italiano, Buenos Aires, Argentina.
  • Biagiola DA; Unidad de Trasplante Hepático, Hospital Italiano, Buenos Aires, Argentina.
  • Iaquinandi JC; Unidad de Trasplante Hepático, Hospital Italiano, Buenos Aires, Argentina.
  • Santofimia-Castaño P; Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France.
  • Iovanna J; Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France.
  • Incardona C; Unidad de Trasplante Hepático, Hospital Italiano, Buenos Aires, Argentina.
  • Chuluyan E; Fundación GADOR, Buenos Aires, Argentina.
Transpl Int ; 31(12): 1357-1368, 2018 12.
Article em En | MEDLINE | ID: mdl-29974521
A double-blind randomized controlled trial was performed to compare the safety and efficacy of α-lipoic acid (ALA) in liver transplantation (LT). The grafts were randomized to receive ALA or placebo before the cold ischemia time. Furthermore, patients transplanted with the ALA-perfused graft received 600 mg of intravenous ALA, while patients with the nonperfused graft received the placebo just before graft reperfusion. Hepatic biopsy was performed 2 h postreperfusion. Blood samples were collected before, during and 1 and 2 days after reperfusion. Quantitative polymerase chain reaction (qPCR) analysis was performed on biopsies to assess genes involved in the response to hypoxia, apoptosis, cell growth, survival and proliferation, cytokine production and tissue damage protection. Nine of 40 patients developed postreperfusion syndrome (PRS), but seven of them belonged to the control group. There was a decrease in PHD2 and an increase in alpha subunit of hypoxia-inducible factor-1 (HIF-1α) and baculoviral IAP repeat containing 2 (Birc2) transcript levels in the biopsies from the ALA-treated versus the control group of patients. Additionally, plasma levels of alarmins were lower in ALA-treated patients than control patients, which suggests that ALA-treated grafts are less inflammatory than untreated grafts. These results showed that ALA is safe for use in LT, induces gene changes that protect against hypoxia and oxidative stress and reduces the appearance of PRS.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Traumatismo por Reperfusão / Ácido Tióctico / Transplante de Fígado Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Transpl Int Assunto da revista: TRANSPLANTE Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Argentina País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Traumatismo por Reperfusão / Ácido Tióctico / Transplante de Fígado Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Transpl Int Assunto da revista: TRANSPLANTE Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Argentina País de publicação: Suíça